SOAT1 and retinitis pigmentosa 1: We observed that UPA is capable of strongly inhibiting the JAK/STAT pathway in LIF induced rMC-1 cells, an indication to us that this drug and inhibition of the JAK/STAT pathway could be beneficial in the treatment of RP and other retinal degenerations.